Clinical trials for Pancreas cancer
154 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Early Access
Kidney cancer
Pancreas cancer
Required histologic types
Clear cell carcinoma
Required histologic sub types
Neuroendocrine tumor
Required disease stage
Localized
Required genetic anomalies
Von Hippel-Lindau syndrome (VHL)
1 recruiting site
Merck Sharp & Dohme LLC
Phase 3
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
Stomach and esophageal cancer
Cervical / Vulvar / Vaginal cancer
Small intestine and appendix cancer
#NCT07544654
#2025-523869-22-00
Required histologic sub types
Neuroendocrine carcinoma
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Chemotherapy
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
Antibody Drug Conjugates (ADC)
1 recruiting site
Boehringer Ingelheim
Phase 3
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
Small intestine and appendix cancer
#NCT07087054
#2024-519875-24-00
Required histologic types
Ileum cancer
Required histologic sub types
Neuroendocrine tumor
Required number of previous lines of therapy for current stage of disease
None
6 recruiting sites
Crinetics Pharmaceuticals Inc.
Phase 3
Pancreas cancer
#NCT07252232
#2025-523495-23-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Localized
Required genetic anomalies
Other KRAS
HRAS
KRAS G12C
KRAS G12D
KRAS non G12C
NRAS
RAS
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery
Chemotherapy
Excluded previous treatments at localized stage
Targeted therapy
3 recruiting sites
Revolution Medicines, Inc.
Phase 3
Pancreas cancer
Stomach and esophageal cancer
#NCT06784752
#2024-518325-15-00
Required histologic types
Stomach
Required histologic sub types
Neuroendocrine tumor
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Required SSTR metabolic imaging statuses
SSTR Positive
5 recruiting sites
Novartis
Phase 3
Pancreas cancer
Stomach and esophageal cancer
#NCT05477576
#2023-509334-19-00
Required histologic types
Stomach
Required histologic sub types
Neuroendocrine tumor
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Somatostatin analogs
Required SSTR metabolic imaging statuses
SSTR Positive
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
2 recruiting sites
RayzeBio, Inc
Phase 3
Lung cancer
Colon cancer
Rectal cancer
Pancreas cancer
Sarcoma and GIST
#NCT06332274
#2023-503316-33-00
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Soft tissue sarcoma
Required disease stage
Localized
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery
Chemotherapy
Required previous treatments at advanced or metastatic stage
Surgery
Chemotherapy
Excluded genetic anomalies
EGFR
Excluded previous treatments at localized stage
Immunotherapy
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
4 recruiting sites
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3
Pancreas cancer
#NCT04167007
#2024-511904-18-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
7 recruiting sites
Assistance Publique - Hôpitaux de Paris
Phase 3
Pancreas cancer
#NCT00268411
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at localized stage
Chemotherapy
Radiotherapy
Excluded previous treatments at advanced or metastatic stage
Chemotherapy
Radiotherapy
14 recruiting sites
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 3
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT04498767
Required disease stage
Metastatic
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
2 recruiting sites
EORTC - Organisation Européenne pour la Recherche et le Traitement du Cancer